The Pfizer Foundation Inc logo

New Mechanisms and Emerging Treatment Options in Metastatic Castration Resistant Prostate Cancer (mCRPC) Grant

The Pfizer Foundation Inc

Funding Amount

US $75,000 - US $250,000

Deadline

Deadline not published

Grant Type

Foundation

Overview

The grant titled 'New Mechanisms and Emerging Treatment Options in Metastatic Castration Resistant Prostate Cancer (mCRPC)' by Pfizer aims to support independent medical education focused on innovative therapies such as EZH2 inhibition. It targets increasing awareness among healthcare professionals regarding the mechanisms of action of emerging therapies, the role of novel mechanisms in disease progression, and the need for novel therapies in mCRPC. This initiative underscores Pfizer's commitment to improving patient outcomes in oncology.

Pfizer Inc.
Pfizer's purpose is breakthroughs that change patients’ lives. It was Charles Pfizer’s vision at the beginning and it holds true today.
New Mechanisms and Emerging Treatment Options in Metastatic Castration Resistant Prostate Cancer (mCRPC)
Overview
This competitive grant program seeks to support independent medical education addressing the new mechanisms in mCRPC including EZH2 inhibition and its possible role in prostate cancer and the continued unmet need for novel therapies in mCRPC.
Project Types and Area of Interest
Projects that will be considered for Pfizer support will focus on increasing healthcare professional awareness and understanding in the following areas:
differentiated mechanism of action (MOA) of emerging therapies including EZH2 inhibition and its possible role in prostate cancerEZH2 and other novel mechanisms of disease (MOD) and their role in prostate cancer progressionthe investigational thesis of how concomitant EZH2 and AR inhibition may suppress prostate cancer while delaying or overcoming ARPi resistancethe continued unmet need for novel therapies in mCRPC
mCRPC therapies beyond chemotherapy
ongoing clinical trials that may be an option for patients today

What The Pfizer Foundation Inc actually gave

Source: IRS Form 990-PF, 2024

Grants in 2024
9,306
Total given
$23.24M
IRS Form 990-PF, 2024. Amounts as reported by the funder. Full 990 history →

Focus Areas & Funding Uses

Fields of Work

  • Science research
  • Healthcare

Categories

Browse similar grants by category

Related Grants

Open grants from this funder and similar programs

Your AI grants department

Ready to apply for New Mechanisms and Emerging Treatment Options in Metastatic Castration Resistant Prostate Cancer (mCRPC) Grant?

Grantable helps you assess fit, draft narratives, and track deadlines — so you can submit stronger applications, faster.

You found New Mechanisms and Emerging Treatment Options in Metastatic Castration Resistant Prostate Cancer (mCRPC) Grant. Now let's win it.

Start writing